-
Do you use a pelvic exam to screen for sexually transmitted infections, check for ovarian and other gynecologic cancers, or determine whether women should receive hormonal contraceptives? If so, your practice is not supported by scientific evidence and is not recommended by any U.S. organization, according to newly published research.
-
The trend over the past several years toward more progressive federal and state sex education policymaking hit something of a wall in 2011.
-
New research points to the need for more potent approaches to containing the genital herpes simplex virus (HSV).
-
-
Establishing the CV Safety Profile of ADHD Meds in Children and Young Adults; If You're Already on a Statin, Does Adding Niacin Help?; Adverse Effects on Semen from SSRI Treatment of Premature Ejaculation; Comparing Two High-Intensity Statin Regimens: Atorvastatin and Rosuvastatin; The Effect of Adiposity on Insulin Pharmacodynamics; Psoriasis Predisposes to Serious Infections
-
Vascular endothelial growth factor (vegf) is a key factor in the normal and tumor microenvironment regulating angiogenesis.
-
In this issue: New treatment for TB; safety of dabigatran; quality of antidepressants; systolic hypertension treatment; and FDA actions.
-
-
The authors performed a randomized, double-blind study to compare the effects of progestin-only and combined hormonal contraceptive pills on rates of breastfeeding continuation in postpartum women.
-
How often are we asked whether a patient who has had severe nausea and vomiting in early pregnancy has a greater chance of adverse outcome in her pregnancy?
